Show source-provided references
3. Rathore, R., and Van Tine, B.A. (2021). Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies. J. Clin. Med., 10.
10.3390/jcm10061182 ↗4. Zhao, X., Wu, Q., Gong, X., Liu, J., and Ma, Y. (2021). Osteosarcoma: A review of current and future therapeutic approaches. Biomed. Eng. Online, 20.
10.1186/s12938-021-00860-0 ↗8. Using functional nanomaterials to target and regulate the tumor microenvironment: Diagnostic and therapeutic applications
10.1002/adma.201300299 ↗9. Self-Assembled Peptide-Based Nanodrugs: Molecular Design, Synthesis, Functionalization, and Targeted Tumor Bioimaging and Biotherapy
10.1002/smll.202205787 ↗12. Chen, C., Wang, S., Wang, J., Yao, F., Tang, X., and Guo, W. (2023). Nanosized drug delivery strategies in osteosarcoma chemotherapy. APL Bioeng., 7.
10.1063/5.0137026 ↗13. Fatema, K.N., Li, L.L., Ahmad, K., Kim, J., and Lee, D.W. (2025). Development of Multifunctional PAA-Alginate-Carboxymethyl Cellulose Hydrogel-Loaded Fiber-Reinforced Biomimetic Scaffolds for Controlled Release of Curcumin. Int. J. Biol. Macromol., 301.
10.1016/j.ijbiomac.2025.140449 ↗16. Design and evaluation of a multi-responsive dual-modality bone-targeted drug delivery vehicle for the treatment of osteosarcoma
10.1016/j.ijpharm.2025.125191 ↗17. IL-11-Engineered Macrophage Membrane-Coated Reactive Oxygen Species-Responsive Nanoparticles for Targeted Delivery of Doxorubicin to Osteosarcoma
19. Therapeutic coordination polymers: Tailoring drug release through metal-ligand interactions
10.1039/D4SC00732H ↗20. Cao, J., Zhu, C., Cao, Z., and Ke, X. (2024). CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma. Int. J. Biol. Macromol., 267.
10.1016/j.ijbiomac.2024.130915 ↗21. Sequential drug release nanocomposites for synergistic therapy in disease treatment
10.1039/D5TB00026B ↗22. Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma
10.1080/10717544.2023.2181743 ↗23. Targeted and intracellular delivery of protein therapeutics by a boronated polymer for the treatment of bone tumors
24. iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma
10.2147/IJN.S494151 ↗25. A multifunctional biomimetic nanoplatform for image-guideded photothermal-ferroptotic synergistic osteosarcoma therapy
26. Wei, X., Feng, J., Chen, L., Zhang, C., Liu, Y., Zhang, Y., Xu, Y., Zhang, J., Wang, J., and Yang, H. (2024). METTL3-Mediated m6A Modification of LINC00520 Confers Glycolysis and Chemoresistance in Osteosarcoma via Suppressing Ubiquitination of ENO1. Cancer Lett., 217194.
10.1016/j.canlet.2024.217194 ↗27. Discovery of 2-Amino-3-Cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis
10.1021/acs.jmedchem.2c00004 ↗29. Bioinspired Tumor-Targeting and Biomarker-Activatable Cell-Material Interfacing System Enhances Osteosarcoma Treatment via Biomineralization
10.1002/advs.202302272 ↗31. Biomimetic Targeted Co-Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma
10.1002/advs.202410427 ↗33. An “Outer Piezoelectric and Inner Epigenetic” Logic-Gated PANoptosis for Osteosarcoma Sono-Immunotherapy and Bone Regeneration
10.1002/adma.202415814 ↗34. Lian, H., Zhang, J., Hou, S., Ma, S., Yu, J., Zhao, W., Zhao, D., and Zhang, Z. (2024). Immunotherapy of osteosarcoma based on immune microenvironment modulation. Front. Immunol., 15.
10.3389/fimmu.2024.1498060 ↗35. CGREF1 Modulates Osteosarcoma Proliferation by Regulating the Cell Cycle Through the Wnt/β-Catenin Signaling Pathway
10.1186/s10020-024-01038-9 ↗36. Enhanced pyroptosis induction with pore-forming gene delivery for osteosarcoma microenvironment reshaping
37. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
10.1016/j.apsb.2024.03.022 ↗38. Copper-Loaded Nanoheterojunction Enables Superb Orthotopic Osteosarcoma Therapy via Oxidative Stress and Cell Cuproptosis
10.1021/acsnano.3c04903 ↗39. Li, M., Wang, M., Huang, J., Tang, S., Yang, J., Xu, Z., Xu, G., Chen, X., Liu, J., and Yang, C. (2024). High-performance pyrite nano-catalyst driven photothermal/chemodynamic synergistic therapy for Osteosarcoma. J. Nanobiotechnol., 22.
10.1186/s12951-024-02419-2 ↗42. Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy
10.1021/acsami.0c08992 ↗43. W-Doped TiO2 Nanorods for Multimode Tumor Eradication in Osteosarcoma Models Under Single Ultrasound Irradiation
10.1021/acsami.1c14701 ↗44. High-Efficiency Gold Nanoaggregates for NIR LED-Driven Sustained Mild Photothermal Therapy Achieving Complete Tumor Eradication and Immune Enhancement
10.1002/adma.202412191 ↗45. Liang, Y., Wang, C., Yu, S., Fan, Y., Jiang, Y., Zhou, R., Yan, W., and Sun, Y. (2023). IOX1 Epigenetically Enhanced Photothermal Therapy of 3D-Printing Silicene Scaffolds Against Osteosarcoma with Favorable Bone Regeneration. Mater. Today Bio, 23.
10.1016/j.mtbio.2023.100887 ↗46. Luo, T., Jiang, M., Cheng, Z., Lin, Y., Chen, Y., Zhang, Z., Zhou, J., Zhou, W., Yu, X.F., and Li, S. (2023). Biodegradable FePS3 nanoplatform for efficient treatment of osteosarcoma by combination of gene and NIR-II photothermal therapy. J. Nanobiotechnol., 21.
10.1186/s12951-023-01961-9 ↗47. The combination of eddy thermal effect of biodegradable magnesium with immune checkpoint blockade shows enhanced efficacy against osteosarcoma
48. Yu, K., Zhou, H., Xu, Y., Cao, Y., Zheng, Y., and Liang, B. (2023). Engineering a triple-functional magnetic gel driving mutually-synergistic mild hyperthermia-starvation therapy for osteosarcoma treatment and augmented bone regeneration. J. Nanobiotechnol., 21.
10.1186/s12951-023-01955-7 ↗50. Lukin, I., Erezuma, I., Desimone, M.F., and Zhang, Y.S.A. (2023). Dolatshahi-Pirouz, and G. Orive, Nanomaterial-based drug delivery of immunomodulatory factors for bone and cartilage tissue engineering. Biomater. Adv., 154.
10.1016/j.bioadv.2023.213637 ↗51. Shi, Q., Lu, Y., Zhang, G., Yang, X., Li, R., Zhang, G., Guo, X., Song, J., and Ding, Q. (2022). Multifunctional Mesoporous Silica Nanoparticles for pH-Response and Photothermy Enhanced Osteosarcoma Therapy. Colloids Surf. B Biointerfaces, 217.
10.1016/j.colsurfb.2022.112615 ↗52. FePSe3-Nanosheets-Integrated Cryogenic-3D-Printed Multifunctional Calcium Phosphate Scaffolds for Synergistic Therapy of Osteosarcoma
10.1002/smll.202303636 ↗53. Wang, L., Dai, Z., Bi, J., Chen, Y., Wang, Z., Sun, Z., Ji, Z., Wang, H., Zhang, Y., and Wang, L. (2024). Polydopamine-functionalized calcium-deficient hydroxyapatite 3D-printed scaffold with sustained doxorubicin release for synergistic chemo-photothermal therapy of osteosarcoma and accelerated bone regeneration. Mater. Today Bio, 29.
10.1016/j.mtbio.2024.101253 ↗54. Neodymium and manganese ions co-doped whitlockite for temperature monitoring, photothermal therapy, and bone tissue repair in osteosarcoma
10.1016/j.jcis.2023.09.186 ↗55. Supercritical CO2-Assisted Fabrication of CM-PDA/SF/nHA Nanofibrous Scaffolds for Bone Regeneration and Chemo-Photothermal Therapy Against Osteosarcoma
10.1039/D3BM00532A ↗59. Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications
10.1002/advs.202303617 ↗61. Du, S., Guan, Y., Xie, A., Yan, Z., Gao, S., Li, W., Rao, L., Chen, X., and Chen, T. (2023). Extracellular vesicles: A rising star for therapeutics and drug delivery. J. Nanobiotechnol., 21.
10.1186/s12951-023-01973-5 ↗62. Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect
10.2147/IJN.S379917 ↗63. Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo
10.1080/10717544.2022.2141921 ↗64. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis
10.2147/IJN.S372851 ↗65. Chen, W., Li, Z., Yu, N., Zhang, L., Li, H., Chen, Y., Gong, F., Lin, W., He, X., and Wang, S. (2023). Bone-Targeting Exosome Nanoparticles Activate Keap1/Nrf2/GPX4 Signaling Pathway to Induce Ferroptosis in Osteosarcoma Cells. J. Nanobiotechnol., 21.
10.1186/s12951-023-02129-1 ↗66. Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating P38/JNK Signaling Pathway
10.2147/IJN.S446594 ↗67. Wang, Z., He, Z., Wan, J., Chen, A., Cheng, P., and Zhu, W. (2024). EphA2-specific microvesicles derived from tumor cells facilitate the targeted delivery of chemotherapeutic drugs for osteosarcoma therapy. J. Nanobiotechnol., 22.
10.1186/s12951-024-02372-0 ↗68. Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors
10.1016/j.ijbiomac.2020.08.068 ↗70. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway
10.2147/IJN.S398046 ↗71. Transportation of AIE-visualized nanoliposomes is dominated by the protein corona
10.1093/nsr/nwab068 ↗73. Long circulating liposomal platform utilizing hydrophilic polymer-based surface modification: Preparation, characterisation, and biological evaluation
10.1016/j.ijpharm.2024.124465 ↗74. Ren, K., Cao, X., Zheng, L., Liu, S., Li, L., Cheng, L., Tian, T., Tong, X., Wang, H., and Jiang, L. (2024). Liposomes decorated with β-conglycinin and glycinin: Construction, structure and in vitro digestive stability. Int. J. Biol. Macromol., 269.
10.1016/j.ijbiomac.2024.131900 ↗75. Combined multispectral analysis and molecular docking to research the interaction of soybean isolate protein with different kinds of phospholipid liposomes and its effect on liposome properties
10.1016/j.foodchem.2025.143160 ↗76. Chen, X.-A., Chuang, C.-C., Chen, C.-C., Lee, C.-Y., Chin, C.-Y., Young, J.-J., Bai, M.-Y., and Chuang, C.-C. (2024). Polyelectrolyte-coated liposomes microfluidically assembled in one-step for enhancing cell endocytosis and in-vivo immune responses. Colloids Surf. B Biointerfaces, 241.
10.1016/j.colsurfb.2024.114030 ↗78. Zhang, W., Liu, Y., Luo, Y., Xu, J., Zhang, B., Feng, P., Guo, C., Wang, Y., Huang, Z., and Kong, Q. (2025). Reactivating P53 to treat osteosarcoma: A tetrahedral framework nucleic acids-based approach. Int. J. Biol. Macromol., 304.
10.1016/j.ijbiomac.2025.140765 ↗80. Modeling based dynamics mechanism and pathway of liposome penetration in multicellular tumor spheroid for liposome optimization
10.1016/j.ijpharm.2025.125237 ↗81. Han, Z., Peng, X., Yang, Y., Yi, J., Zhao, D., Bao, Q., Long, S., Yu, S.-X., Xu, X.-X., and Liu, B. (2022). Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis. Biosens. Bioelectron., 217.
10.1016/j.bios.2022.114709 ↗83. NGR-Modified CAF-Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma
10.1002/advs.202410918 ↗84. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1
10.1186/s12943-023-01804-z ↗85. Osteosarcoma Cell-Derived Migrasomes Promote Macrophage M2 Polarization to Aggravate Osteosarcoma Proliferation and Metastasis
10.1002/advs.202409870 ↗88. Wang, J., Zhang, H., Sun, X., Wang, X., Ren, T., Huang, Y., Zhang, R., Zheng, B., and Guo, W. (2020). Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients. J. Nanobiotechnology, 18.
10.1186/s12951-020-00710-6 ↗89. Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours
10.1016/j.addr.2021.114030 ↗91. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
10.1136/jitc-2020-001703 ↗92. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma
10.2147/IJN.S346685 ↗93. Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human Liver Cancer Cells
10.2147/IJN.S452989 ↗94. Wang, J., Liang, S., Chen, S., Ma, T., Chen, M., Niu, C., Leng, Y., and Wang, L. (2024). Bacterial outer membrane vesicle-cancer cell hybrid membrane-coated nanoparticles for sonodynamic therapy in the treatment of breast cancer bone metastasis. J. Nanobiotechnology, 22.
10.1186/s12951-024-02619-w ↗95. Multimodal layer-by-layer nanoparticles: A breakthrough in gene and drug delivery for osteosarcoma
10.1039/D4TB01541J ↗97. Wang, Y., Zhang, L., Zhao, G., Zhang, Y., Zhan, F., Chen, Z., He, T., Cao, Y., Hao, L., and Wang, Z. (2022). Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms. J. Nanobiotechnology, 20.
10.1186/s12951-021-01201-y ↗98. Overcoming therapeutic failure in osteosarcoma via Apatinib-encapsulated hydrophobic poly(ester amide) nanoparticles
10.1039/D0BM01296C ↗